EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival

Dimyana Neufeldt, Arne Schmidt, Elisa Mohr, Dongchao Lu, Shambhabi Chatterjee, Maximilian Fuchs, Ke Xiao, Wen Pan, Sarah Cushman, Christopher Jahn, Malte Juchem, Hannah Jill Hunkler und 13 weitere

Basic Research in Cardiology · 2024

DOI: 10.1007/s00395-024-01048-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic Research in Cardiology, 2024. Verfasst von Dimyana Neufeldt und 24 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Myocytes, Cardiac, RNA, Circular, Cardiomyopathy, Hypertrophic, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, HORIZON EUROPE European Research Council, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy (HCM) constitutes the most common genetic cardiac disorder. However, current pharmacotherapeutics are mainly symptomatic and only partially address underlying molecular mechanisms. Circular RNAs (circRNAs) are a recently discovered class of non-coding RNAs and emerged as specific and powerful regulators of cellular functions. By performing global circRNA-specific next generation sequencing in cardiac tissue of patients with hypertrophic cardiomyopathy compared to healthy donors, we identified circZFPM2 (hsa_circ_0003380). CircZFPM2, which derives from the ZFPM2 gene locus, is a highly conserved regulatory circRNA that is strongly induced in HCM tissue. In vitro loss-of-function experiments were performed in neonatal rat cardiomyocytes, human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), and HCM-patient-derived hiPSC-CMs. A knockdown of circZFPM2 was found to induce cardiomyocyte hypertrophy and compromise mitochondrial respiration, leading to an increased production of reactive oxygen species and apoptosis. In contrast, delivery of recombinant circZFPM2, packaged in lipid-nanoparticles or using AAV-based overexpression, rescued cardiomyocyte hypertrophic gene expression and promoted cell survival. Additionally, HCM-derived cardiac organoids exhibited improved contractility upon CM-specific overexpression of circZFPM2. Multi-Omics analysis further promoted our hypothesis, showing beneficial effects of circZFPM2 on cardiac contractility and mitochondrial function. Collectively, our data highlight that circZFPM2 serves as a promising target for the treatment of cardiac hypertrophy including HCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacRNA, CircularCardiomyopathy, HypertrophicInduced Pluripotent Stem CellsCell SurvivalApoptosisHumansAnimalsRatsCells, CulturedReactive Oxygen SpeciesRNAAnimals, NewbornMitochondria, HeartTranscription Factors

Stichwörter der Autor:innen

Cardiac hypertrophyCircular RNAHeart organoidsHuman induced pluripotent stem cell-derived cardiomyocytesHypertrophic cardiomyopathyNon-coding RNA

Substanzen

RNA, CircularReactive Oxygen SpeciesRNATranscription Factors

Autor:innen und Institutionen

  • Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
  • Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany.
  • Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany.
  • Institute of Molecular and Cell Biology, A*Star, Singapore, Singapore.
  • Institute of Toxicology, Hannover Medical School, Hannover, Germany.
  • Core Facility Proteomics, Institute of Toxicology, Hannover, Germany.

ORCID-Profile: Thomas Thum

Förderung

  • European Research Council
  • HORIZON EUROPE European Research Council
  • Deutsche Forschungsgemeinschaft
  • Medizinische Hochschule Hannover (MHH)

Zitieren

APA

Neufeldt, D., Schmidt, A., Mohr, E., Lu, D., Chatterjee, S., Fuchs, M., Xiao, K., Pan, W., Cushman, S., Jahn, C., Juchem, M., Hunkler, H. J., Cipriano, G., Jürgens, B., Schmidt, K., Groß, S., Jung, M., Hoepfner, J., Weber, N., …, & Bär, C. (2024). Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival. Basic Research in Cardiology. https://doi.org/10.1007/s00395-024-01048-y

Vancouver

Neufeldt D, Schmidt A, Mohr E, Lu D, Chatterjee S, Fuchs M, et al. Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival. Basic Research in Cardiology. 2024. doi:10.1007/s00395-024-01048-y

BibTeX
@article{Neufeldt2024,
  author = {Neufeldt, Dimyana and Schmidt, Arne and Mohr, Elisa and Lu, Dongchao and Chatterjee, Shambhabi and Fuchs, Maximilian and Xiao, Ke and Pan, Wen and Cushman, Sarah and Jahn, Christopher and Juchem, Malte and Hunkler, Hannah Jill and Cipriano, Giuseppe and Jürgens, Bjarne and Schmidt, Kevin and Groß, Sonja and Jung, Mira and Hoepfner, Jeannine and Weber, Natalie and Foo, Roger and Pich, Andreas and Zweigerdt, Robert and Kraft, Theresia and Thum, Thomas and Bär, Christian},
  title = {Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival},
  journal = {Basic Research in Cardiology},
  year = {2024},
  doi = {10.1007/s00395-024-01048-y}
}
Kostenlos starten →